Global Whole Genome Amplification Market

Global Whole Genome Amplification Market - Industry Analysis Size Share Growth Trends and Forecast 2025 - 2032

ID: SAC1882514   Published Date: June 2024    Number of Pages: 300-350   

Year Considered

Historic Years
2020 to 2024 Base Year
2025 Estimated Year
2026 Projected Years
2027 to 2033

Report Description

The Whole Genome Amplification market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031. Considering the influence of COVID-19 on the global Whole Genome Amplification market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions. This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery. Under COVID-19 Outbreak, how the Whole Genome Amplification Industry will develop is also analyzed in detail in Chapter 1.8 of this report. Major Players in Whole Genome Amplification market are: GE Healthcare Sigma-Aldrich LGC Group QIAGEN NV Most important types of Whole Genome Amplification products covered in this report are: Single Cell WGA Kit Complete WGA Kit WGA Reamplification Kit WGA & Chip DNA Kit Others Most widely used downstream fields of Whole Genome Amplification market covered in this report are: Drug Discovery & Development Disease Diagnosis Agriculture & Veterinary Research Forensics Others Major Regions or countries covered in this report: North America Europe China Japan Middle East and Africa South America India South Korea Southeast Asia Others In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations. In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out. In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.

Table of Content 1 Whole Genome Amplification Introduction and Market Overview 1.1 Objectives of the Study 1.2 Overview of Whole Genome Amplification 1.3 Whole Genome Amplification Market Scope and Market Size Estimation 1.3.1 Market Concentration Ratio and Market Maturity Analysis 1.3.2 Global Whole Genome Amplification Revenue and Growth Rate from 2019-2031 1.4 Market Segmentation 1.4.1 Types of Whole Genome Amplification 1.4.2 Applications of Whole Genome Amplification 1.4.3 Research Regions 1.5 Market Dynamics 1.5.1 Whole Genome Amplification Industry Trends 1.5.2 Whole Genome Amplification Drivers 1.5.3 Whole Genome Amplification Market Challenges 1.5.4 Whole Genome Amplification Market Restraints 1.6 Industry News and Policies by Regions 1.6.1 Industry News 1.6.2 Industry Policies 1.7 Mergers & Acquisitions, Expansion Plans 1.8 Whole Genome Amplification Industry Development Trends under COVID-19 Outbreak 1.8.1 Global COVID-19 Status Overview 1.8.2 Influence of COVID-19 Outbreak on Whole Genome Amplification Industry Development 2 Industry Chain Analysis 2.1 Upstream Raw Material Supply and Demand Analysis 2.1.1 Global Whole Genome Amplification Major Upstream Raw Material and Suppliers 2.1.2 Raw Material Source Analysis 2.2 Major Players of Whole Genome Amplification 2.2.1 Major Players Manufacturing Base of Whole Genome Amplification in 2020 2.2.2 Major Players Market Distribution in 2020 2.3 Whole Genome Amplification Manufacturing Cost Structure Analysis 2.3.1 Production Process Analysis 2.3.2 Manufacturing Cost Structure of Whole Genome Amplification 2.3.3 Labor Cost of Whole Genome Amplification 2.4 Market Channel Analysis of Whole Genome Amplification 2.5 Major Down Stream Customers by Application 3 Global Whole Genome Amplification Market, by Type 3.1 Global Whole Genome Amplification Revenue and Market Share by Type (2019-2023) 3.2 Global Whole Genome Amplification Production and Market Share by Type (2019-2023) 3.3 Global Whole Genome Amplification Revenue and Growth Rate by Type (2019-2023) 3.3.1 Global Whole Genome Amplification Revenue and Growth Rate of Single Cell WGA Kit 3.3.2 Global Whole Genome Amplification Revenue and Growth Rate of Complete WGA Kit 3.3.3 Global Whole Genome Amplification Revenue and Growth Rate of WGA Reamplification Kit 3.3.4 Global Whole Genome Amplification Revenue and Growth Rate of WGA & Chip DNA Kit 3.3.5 Global Whole Genome Amplification Revenue and Growth Rate of Others 3.4 Global Whole Genome Amplification Price Analysis by Type (2019-2023) 3.4.1 Explanation of Different Type Product Price Trends 4 Whole Genome Amplification Market, by Application 4.1 Downstream Market Overview 4.2 Global Whole Genome Amplification Consumption and Market Share by Application (2019-2023) 4.3 Global Whole Genome Amplification Consumption and Growth Rate by Application (2019-2023) 4.3.1 Global Whole Genome Amplification Consumption and Growth Rate of Drug Discovery & Development (2019-2023) 4.3.2 Global Whole Genome Amplification Consumption and Growth Rate of Disease Diagnosis (2019-2023) 4.3.3 Global Whole Genome Amplification Consumption and Growth Rate of Agriculture & Veterinary (2019-2023) 4.3.4 Global Whole Genome Amplification Consumption and Growth Rate of Research (2019-2023) 4.3.5 Global Whole Genome Amplification Consumption and Growth Rate of Forensics (2019-2023) 4.3.6 Global Whole Genome Amplification Consumption and Growth Rate of Others (2019-2023) 5 Global Whole Genome Amplification Consumption, Revenue ($) by Region (2019-2023) 5.1 Global Whole Genome Amplification Revenue and Market Share by Region (2019-2023) 5.2 Global Whole Genome Amplification Consumption and Market Share by Region (2019-2023) 5.3 Global Whole Genome Amplification Consumption, Revenue, Price and Gross Margin (2019-2023) 5.4 North America Whole Genome Amplification Consumption, Revenue, Price and Gross Margin (2019-2023) 5.4.1 North America Whole Genome Amplification Market Under COVID-19 5.4.2 North America Whole Genome Amplification SWOT Analysis 5.5 Europe Whole Genome Amplification Consumption, Revenue, Price and Gross Margin (2019-2023) 5.5.1 Europe Whole Genome Amplification Market Under COVID-19 5.5.2 Europe Whole Genome Amplification SWOT Analysis 5.6 China Whole Genome Amplification Consumption, Revenue, Price and Gross Margin (2019-2023) 5.6.1 China Whole Genome Amplification Market Under COVID-19 5.6.2 China Whole Genome Amplification SWOT Analysis 5.7 Japan Whole Genome Amplification Consumption, Revenue, Price and Gross Margin (2019-2023) 5.7.1 Japan Whole Genome Amplification Market Under COVID-19 5.7.2 Japan Whole Genome Amplification SWOT Analysis 5.8 Middle East and Africa Whole Genome Amplification Consumption, Revenue, Price and Gross Margin (2019-2023) 5.8.1 Middle East and Africa Whole Genome Amplification Market Under COVID-19 5.8.2 Middle East and Africa Whole Genome Amplification SWOT Analysis 5.9 India Whole Genome Amplification Consumption, Revenue, Price and Gross Margin (2019-2023) 5.9.1 India Whole Genome Amplification Market Under COVID-19 5.9.2 India Whole Genome Amplification SWOT Analysis 5.10 South America Whole Genome Amplification Consumption, Revenue, Price and Gross Margin (2019-2023) 5.10.1 South America Whole Genome Amplification Market Under COVID-19 5.10.2 South America Whole Genome Amplification SWOT Analysis 5.11 South Korea Whole Genome Amplification Consumption, Revenue, Price and Gross Margin (2019-2023) 5.11.1 South Korea Whole Genome Amplification Market Under COVID-19 5.11.2 South Korea Whole Genome Amplification SWOT Analysis 5.12 Southeast Asia Whole Genome Amplification Consumption, Revenue, Price and Gross Margin (2019-2023) 5.12.1 Southeast Asia Whole Genome Amplification Market Under COVID-19 5.12.2 Southeast Asia Whole Genome Amplification SWOT Analysis 6 Global Whole Genome Amplification Production by Top Regions (2019-2023) 6.1 Global Whole Genome Amplification Production by Top Regions (2019-2023) 6.2 North America Whole Genome Amplification Production and Growth Rate 6.3 Europe Whole Genome Amplification Production and Growth Rate 6.4 China Whole Genome Amplification Production and Growth Rate 6.5 Japan Whole Genome Amplification Production and Growth Rate 6.6 India Whole Genome Amplification Production and Growth Rate 7 Global Whole Genome Amplification Consumption by Regions (2019-2023) 7.1 Global Whole Genome Amplification Consumption by Regions (2019-2023) 7.2 North America Whole Genome Amplification Consumption and Growth Rate 7.3 Europe Whole Genome Amplification Consumption and Growth Rate 7.4 China Whole Genome Amplification Consumption and Growth Rate 7.5 Japan Whole Genome Amplification Consumption and Growth Rate 7.6 Middle East & Africa Whole Genome Amplification Consumption and Growth Rate 7.7 India Whole Genome Amplification Consumption and Growth Rate 7.8 South America Whole Genome Amplification Consumption and Growth Rate 7.9 South Korea Whole Genome Amplification Consumption and Growth Rate 7.10 Southeast Asia Whole Genome Amplification Consumption and Growth Rate 8 Competitive Landscape 8.1 Competitive Profile 8.2 GE Healthcare Market Performance Analysis 8.2.1 Company Profiles 8.2.2 Whole Genome Amplification Product Profiles, Application and Specification 8.2.3 GE Healthcare Sales, Revenue, Price, Gross Margin 2019-2023 8.2.4 Company Recent Development 8.2.5 Strategies for Company to Deal with the Impact of COVID-19 8.3 Sigma-Aldrich Market Performance Analysis 8.3.1 Company Profiles 8.3.2 Whole Genome Amplification Product Profiles, Application and Specification 8.3.3 Sigma-Aldrich Sales, Revenue, Price, Gross Margin 2019-2023 8.3.4 Company Recent Development 8.3.5 Strategies for Company to Deal with the Impact of COVID-19 8.4 LGC Group Market Performance Analysis 8.4.1 Company Profiles 8.4.2 Whole Genome Amplification Product Profiles, Application and Specification 8.4.3 LGC Group Sales, Revenue, Price, Gross Margin 2019-2023 8.4.4 Company Recent Development 8.4.5 Strategies for Company to Deal with the Impact of COVID-19 8.5 QIAGEN NV Market Performance Analysis 8.5.1 Company Profiles 8.5.2 Whole Genome Amplification Product Profiles, Application and Specification 8.5.3 QIAGEN NV Sales, Revenue, Price, Gross Margin 2019-2023 8.5.4 Company Recent Development 8.5.5 Strategies for Company to Deal with the Impact of COVID-19 9 Global Whole Genome Amplification Market Analysis and Forecast by Type and Application 9.1 Global Whole Genome Amplification Market Revenue & Volume Forecast, by Type (2021-2026) 9.1.1 Single Cell WGA Kit Market Revenue and Volume Forecast (2021-2026) 9.1.2 Complete WGA Kit Market Revenue and Volume Forecast (2021-2026) 9.1.3 WGA Reamplification Kit Market Revenue and Volume Forecast (2021-2026) 9.1.4 WGA & Chip DNA Kit Market Revenue and Volume Forecast (2021-2026) 9.1.5 Others Market Revenue and Volume Forecast (2021-2026) 9.2 Global Whole Genome Amplification Market Revenue & Volume Forecast, by Application (2021-2026) 9.2.1 Drug Discovery & Development Market Revenue and Volume Forecast (2021-2026) 9.2.2 Disease Diagnosis Market Revenue and Volume Forecast (2021-2026) 9.2.3 Agriculture & Veterinary Market Revenue and Volume Forecast (2021-2026) 9.2.4 Research Market Revenue and Volume Forecast (2021-2026) 9.2.5 Forensics Market Revenue and Volume Forecast (2021-2026) 9.2.6 Others Market Revenue and Volume Forecast (2021-2026) 10 Whole Genome Amplification Market Supply and Demand Forecast by Region 10.1 North America Market Supply and Demand Forecast (2021-2026) 10.2 Europe Market Supply and Demand Forecast (2021-2026) 10.3 China Market Supply and Demand Forecast (2021-2026) 10.4 Japan Market Supply and Demand Forecast (2021-2026) 10.5 Middle East and Africa Market Supply and Demand Forecast (2021-2026) 10.6 India Market Supply and Demand Forecast (2021-2026) 10.7 South America Market Supply and Demand Forecast (2021-2026) 10.8 South Korea Market Supply and Demand Forecast (2021-2026) 10.9 Southeast Asia Market Supply and Demand Forecast (2021-2026) 10.10 Explanation of Market Size Trends by Region 10.11 Whole Genome Amplification Market Trends Analysis 11 New Project Feasibility Analysis 11.1 Industry Barriers and New Entrants SWOT Analysis 11.2 Analysis and Suggestions on New Project Investment 12 Expert Interview Record 13 Research Finding and Conclusion 14 Appendix 14.1 Methodology 14.2 Research Data Source  

get in touch

We work with firms all across the US and Europe

  • United States+1
  • United Kingdom+44
  • Afghanistan (‫افغانستان‬‎)+93
  • Albania (Shqipëri)+355
  • Algeria (‫الجزائر‬‎)+213
  • American Samoa+1
  • Andorra+376
  • Angola+244
  • Anguilla+1
  • Antigua and Barbuda+1
  • Argentina+54
  • Armenia (Հայաստան)+374
  • Aruba+297
  • Ascension Island+247
  • Australia+61
  • Austria (Österreich)+43
  • Azerbaijan (Azərbaycan)+994
  • Bahamas+1
  • Bahrain (‫البحرين‬‎)+973
  • Bangladesh (বাংলাদেশ)+880
  • Barbados+1
  • Belarus (Беларусь)+375
  • Belgium (België)+32
  • Belize+501
  • Benin (Bénin)+229
  • Bermuda+1
  • Bhutan (འབྲུག)+975
  • Bolivia+591
  • Bosnia and Herzegovina (Босна и Херцеговина)+387
  • Botswana+267
  • Brazil (Brasil)+55
  • British Indian Ocean Territory+246
  • British Virgin Islands+1
  • Brunei+673
  • Bulgaria (България)+359
  • Burkina Faso+226
  • Burundi (Uburundi)+257
  • Cambodia (កម្ពុជា)+855
  • Cameroon (Cameroun)+237
  • Canada+1
  • Cape Verde (Kabu Verdi)+238
  • Caribbean Netherlands+599
  • Cayman Islands+1
  • Central African Republic (République centrafricaine)+236
  • Chad (Tchad)+235
  • Chile+56
  • China (中国)+86
  • Christmas Island+61
  • Cocos (Keeling) Islands+61
  • Colombia+57
  • Comoros (‫جزر القمر‬‎)+269
  • Congo (DRC) (Jamhuri ya Kidemokrasia ya Kongo)+243
  • Congo (Republic) (Congo-Brazzaville)+242
  • Cook Islands+682
  • Costa Rica+506
  • Côte d’Ivoire+225
  • Croatia (Hrvatska)+385
  • Cuba+53
  • Curaçao+599
  • Cyprus (Κύπρος)+357
  • Czech Republic (Česká republika)+420
  • Denmark (Danmark)+45
  • Djibouti+253
  • Dominica+1
  • Dominican Republic (República Dominicana)+1
  • Ecuador+593
  • Egypt (‫مصر‬‎)+20
  • El Salvador+503
  • Equatorial Guinea (Guinea Ecuatorial)+240
  • Eritrea+291
  • Estonia (Eesti)+372
  • Eswatini+268
  • Ethiopia+251
  • Falkland Islands (Islas Malvinas)+500
  • Faroe Islands (Føroyar)+298
  • Fiji+679
  • Finland (Suomi)+358
  • France+33
  • French Guiana (Guyane française)+594
  • French Polynesia (Polynésie française)+689
  • Gabon+241
  • Gambia+220
  • Georgia (საქართველო)+995
  • Germany (Deutschland)+49
  • Ghana (Gaana)+233
  • Gibraltar+350
  • Greece (Ελλάδα)+30
  • Greenland (Kalaallit Nunaat)+299
  • Grenada+1
  • Guadeloupe+590
  • Guam+1
  • Guatemala+502
  • Guernsey+44
  • Guinea (Guinée)+224
  • Guinea-Bissau (Guiné Bissau)+245
  • Guyana+592
  • Haiti+509
  • Honduras+504
  • Hong Kong (香港)+852
  • Hungary (Magyarország)+36
  • Iceland (Ísland)+354
  • India (भारत)+91
  • Indonesia+62
  • Iran (‫ایران‬‎)+98
  • Iraq (‫العراق‬‎)+964
  • Ireland+353
  • Isle of Man+44
  • Israel (‫ישראל‬‎)+972
  • Italy (Italia)+39
  • Jamaica+1
  • Japan (日本)+81
  • Jersey+44
  • Jordan (‫الأردن‬‎)+962
  • Kazakhstan (Казахстан)+7
  • Kenya+254
  • Kiribati+686
  • Kosovo+383
  • Kuwait (‫الكويت‬‎)+965
  • Kyrgyzstan (Кыргызстан)+996
  • Laos (ລາວ)+856
  • Latvia (Latvija)+371
  • Lebanon (‫لبنان‬‎)+961
  • Lesotho+266
  • Liberia+231
  • Libya (‫ليبيا‬‎)+218
  • Liechtenstein+423
  • Lithuania (Lietuva)+370
  • Luxembourg+352
  • Macau (澳門)+853
  • North Macedonia (Македонија)+389
  • Madagascar (Madagasikara)+261
  • Malawi+265
  • Malaysia+60
  • Maldives+960
  • Mali+223
  • Malta+356
  • Marshall Islands+692
  • Martinique+596
  • Mauritania (‫موريتانيا‬‎)+222
  • Mauritius (Moris)+230
  • Mayotte+262
  • Mexico (México)+52
  • Micronesia+691
  • Moldova (Republica Moldova)+373
  • Monaco+377
  • Mongolia (Монгол)+976
  • Montenegro (Crna Gora)+382
  • Montserrat+1
  • Morocco (‫المغرب‬‎)+212
  • Mozambique (Moçambique)+258
  • Myanmar (Burma) (မြန်မာ)+95
  • Namibia (Namibië)+264
  • Nauru+674
  • Nepal (नेपाल)+977
  • Netherlands (Nederland)+31
  • New Caledonia (Nouvelle-Calédonie)+687
  • New Zealand+64
  • Nicaragua+505
  • Niger (Nijar)+227
  • Nigeria+234
  • Niue+683
  • Norfolk Island+672
  • North Korea (조선 민주주의 인민 공화국)+850
  • Northern Mariana Islands+1
  • Norway (Norge)+47
  • Oman (‫عُمان‬‎)+968
  • Pakistan (‫پاکستان‬‎)+92
  • Palau+680
  • Palestine (‫فلسطين‬‎)+970
  • Panama (Panamá)+507
  • Papua New Guinea+675
  • Paraguay+595
  • Peru (Perú)+51
  • Philippines+63
  • Poland (Polska)+48
  • Portugal+351
  • Puerto Rico+1
  • Qatar (‫قطر‬‎)+974
  • Réunion (La Réunion)+262
  • Romania (România)+40
  • Russia (Россия)+7
  • Rwanda+250
  • Saint Barthélemy+590
  • Saint Helena+290
  • Saint Kitts and Nevis+1
  • Saint Lucia+1
  • Saint Martin (Saint-Martin (partie française))+590
  • Saint Pierre and Miquelon (Saint-Pierre-et-Miquelon)+508
  • Saint Vincent and the Grenadines+1
  • Samoa+685
  • San Marino+378
  • São Tomé and Príncipe (São Tomé e Príncipe)+239
  • Saudi Arabia (‫المملكة العربية السعودية‬‎)+966
  • Senegal (Sénégal)+221
  • Serbia (Србија)+381
  • Seychelles+248
  • Sierra Leone+232
  • Singapore+65
  • Sint Maarten+1
  • Slovakia (Slovensko)+421
  • Slovenia (Slovenija)+386
  • Solomon Islands+677
  • Somalia (Soomaaliya)+252
  • South Africa+27
  • South Korea (대한민국)+82
  • South Sudan (‫جنوب السودان‬‎)+211
  • Spain (España)+34
  • Sri Lanka (ශ්‍රී ලංකාව)+94
  • Sudan (‫السودان‬‎)+249
  • Suriname+597
  • Svalbard and Jan Mayen+47
  • Sweden (Sverige)+46
  • Switzerland (Schweiz)+41
  • Syria (‫سوريا‬‎)+963
  • Taiwan (台灣)+886
  • Tajikistan+992
  • Tanzania+255
  • Thailand (ไทย)+66
  • Timor-Leste+670
  • Togo+228
  • Tokelau+690
  • Tonga+676
  • Trinidad and Tobago+1
  • Tunisia (‫تونس‬‎)+216
  • Turkey (Türkiye)+90
  • Turkmenistan+993
  • Turks and Caicos Islands+1
  • Tuvalu+688
  • U.S. Virgin Islands+1
  • Uganda+256
  • Ukraine (Україна)+380
  • United Arab Emirates (‫الإمارات العربية المتحدة‬‎)+971
  • United Kingdom+44
  • United States+1
  • Uruguay+598
  • Uzbekistan (Oʻzbekiston)+998
  • Vanuatu+678
  • Vatican City (Città del Vaticano)+39
  • Venezuela+58
  • Vietnam (Việt Nam)+84
  • Wallis and Futuna (Wallis-et-Futuna)+681
  • Western Sahara (‫الصحراء الغربية‬‎)+212
  • Yemen (‫اليمن‬‎)+967
  • Zambia+260
  • Zimbabwe+263
  • Åland Islands+358
United States
Security Code:

Select Access

$5500
$7500

Related Reports

Trusted by

Testimonial

"I cannot recommend talking to Success highly enough about planning your business goals. It involves an examination of operations which allows their team discuss the art of the possible."

Sean Fitzgerald

Manhatton, New York

Get in Touch with Us

Report Covers Following Things

  • The Global Whole Genome Amplification Market report delivers detailed insights into the market size and regional market share.

  • It includes historical market data (2020-2024) and forecasts for the period (2025-2031).

  • Provides a thorough competitor analysis, including company share breakdowns and key market strategies.

  • Highlights major market drivers, challenges, unmet needs, and current trends influencing the industry.

  • Tracks recent innovations, significant developments, and active start-ups in the market.

  • Offers extensive guidance on market entry approaches, regulatory frameworks, and reimbursement policies.

  • Conducts a PESTLE analysis to evaluate the socio-political and economic impact on the market.

  • Utilizes Porter's Five Forces analysis to assess competitive dynamics and market structure.

Request Free Sample Report

  • United States+1
  • United Kingdom+44
  • Afghanistan (‫افغانستان‬‎)+93
  • Albania (Shqipëri)+355
  • Algeria (‫الجزائر‬‎)+213
  • American Samoa+1
  • Andorra+376
  • Angola+244
  • Anguilla+1
  • Antigua and Barbuda+1
  • Argentina+54
  • Armenia (Հայաստան)+374
  • Aruba+297
  • Ascension Island+247
  • Australia+61
  • Austria (Österreich)+43
  • Azerbaijan (Azərbaycan)+994
  • Bahamas+1
  • Bahrain (‫البحرين‬‎)+973
  • Bangladesh (বাংলাদেশ)+880
  • Barbados+1
  • Belarus (Беларусь)+375
  • Belgium (België)+32
  • Belize+501
  • Benin (Bénin)+229
  • Bermuda+1
  • Bhutan (འབྲུག)+975
  • Bolivia+591
  • Bosnia and Herzegovina (Босна и Херцеговина)+387
  • Botswana+267
  • Brazil (Brasil)+55
  • British Indian Ocean Territory+246
  • British Virgin Islands+1
  • Brunei+673
  • Bulgaria (България)+359
  • Burkina Faso+226
  • Burundi (Uburundi)+257
  • Cambodia (កម្ពុជា)+855
  • Cameroon (Cameroun)+237
  • Canada+1
  • Cape Verde (Kabu Verdi)+238
  • Caribbean Netherlands+599
  • Cayman Islands+1
  • Central African Republic (République centrafricaine)+236
  • Chad (Tchad)+235
  • Chile+56
  • China (中国)+86
  • Christmas Island+61
  • Cocos (Keeling) Islands+61
  • Colombia+57
  • Comoros (‫جزر القمر‬‎)+269
  • Congo (DRC) (Jamhuri ya Kidemokrasia ya Kongo)+243
  • Congo (Republic) (Congo-Brazzaville)+242
  • Cook Islands+682
  • Costa Rica+506
  • Côte d’Ivoire+225
  • Croatia (Hrvatska)+385
  • Cuba+53
  • Curaçao+599
  • Cyprus (Κύπρος)+357
  • Czech Republic (Česká republika)+420
  • Denmark (Danmark)+45
  • Djibouti+253
  • Dominica+1
  • Dominican Republic (República Dominicana)+1
  • Ecuador+593
  • Egypt (‫مصر‬‎)+20
  • El Salvador+503
  • Equatorial Guinea (Guinea Ecuatorial)+240
  • Eritrea+291
  • Estonia (Eesti)+372
  • Eswatini+268
  • Ethiopia+251
  • Falkland Islands (Islas Malvinas)+500
  • Faroe Islands (Føroyar)+298
  • Fiji+679
  • Finland (Suomi)+358
  • France+33
  • French Guiana (Guyane française)+594
  • French Polynesia (Polynésie française)+689
  • Gabon+241
  • Gambia+220
  • Georgia (საქართველო)+995
  • Germany (Deutschland)+49
  • Ghana (Gaana)+233
  • Gibraltar+350
  • Greece (Ελλάδα)+30
  • Greenland (Kalaallit Nunaat)+299
  • Grenada+1
  • Guadeloupe+590
  • Guam+1
  • Guatemala+502
  • Guernsey+44
  • Guinea (Guinée)+224
  • Guinea-Bissau (Guiné Bissau)+245
  • Guyana+592
  • Haiti+509
  • Honduras+504
  • Hong Kong (香港)+852
  • Hungary (Magyarország)+36
  • Iceland (Ísland)+354
  • India (भारत)+91
  • Indonesia+62
  • Iran (‫ایران‬‎)+98
  • Iraq (‫العراق‬‎)+964
  • Ireland+353
  • Isle of Man+44
  • Israel (‫ישראל‬‎)+972
  • Italy (Italia)+39
  • Jamaica+1
  • Japan (日本)+81
  • Jersey+44
  • Jordan (‫الأردن‬‎)+962
  • Kazakhstan (Казахстан)+7
  • Kenya+254
  • Kiribati+686
  • Kosovo+383
  • Kuwait (‫الكويت‬‎)+965
  • Kyrgyzstan (Кыргызстан)+996
  • Laos (ລາວ)+856
  • Latvia (Latvija)+371
  • Lebanon (‫لبنان‬‎)+961
  • Lesotho+266
  • Liberia+231
  • Libya (‫ليبيا‬‎)+218
  • Liechtenstein+423
  • Lithuania (Lietuva)+370
  • Luxembourg+352
  • Macau (澳門)+853
  • North Macedonia (Македонија)+389
  • Madagascar (Madagasikara)+261
  • Malawi+265
  • Malaysia+60
  • Maldives+960
  • Mali+223
  • Malta+356
  • Marshall Islands+692
  • Martinique+596
  • Mauritania (‫موريتانيا‬‎)+222
  • Mauritius (Moris)+230
  • Mayotte+262
  • Mexico (México)+52
  • Micronesia+691
  • Moldova (Republica Moldova)+373
  • Monaco+377
  • Mongolia (Монгол)+976
  • Montenegro (Crna Gora)+382
  • Montserrat+1
  • Morocco (‫المغرب‬‎)+212
  • Mozambique (Moçambique)+258
  • Myanmar (Burma) (မြန်မာ)+95
  • Namibia (Namibië)+264
  • Nauru+674
  • Nepal (नेपाल)+977
  • Netherlands (Nederland)+31
  • New Caledonia (Nouvelle-Calédonie)+687
  • New Zealand+64
  • Nicaragua+505
  • Niger (Nijar)+227
  • Nigeria+234
  • Niue+683
  • Norfolk Island+672
  • North Korea (조선 민주주의 인민 공화국)+850
  • Northern Mariana Islands+1
  • Norway (Norge)+47
  • Oman (‫عُمان‬‎)+968
  • Pakistan (‫پاکستان‬‎)+92
  • Palau+680
  • Palestine (‫فلسطين‬‎)+970
  • Panama (Panamá)+507
  • Papua New Guinea+675
  • Paraguay+595
  • Peru (Perú)+51
  • Philippines+63
  • Poland (Polska)+48
  • Portugal+351
  • Puerto Rico+1
  • Qatar (‫قطر‬‎)+974
  • Réunion (La Réunion)+262
  • Romania (România)+40
  • Russia (Россия)+7
  • Rwanda+250
  • Saint Barthélemy+590
  • Saint Helena+290
  • Saint Kitts and Nevis+1
  • Saint Lucia+1
  • Saint Martin (Saint-Martin (partie française))+590
  • Saint Pierre and Miquelon (Saint-Pierre-et-Miquelon)+508
  • Saint Vincent and the Grenadines+1
  • Samoa+685
  • San Marino+378
  • São Tomé and Príncipe (São Tomé e Príncipe)+239
  • Saudi Arabia (‫المملكة العربية السعودية‬‎)+966
  • Senegal (Sénégal)+221
  • Serbia (Србија)+381
  • Seychelles+248
  • Sierra Leone+232
  • Singapore+65
  • Sint Maarten+1
  • Slovakia (Slovensko)+421
  • Slovenia (Slovenija)+386
  • Solomon Islands+677
  • Somalia (Soomaaliya)+252
  • South Africa+27
  • South Korea (대한민국)+82
  • South Sudan (‫جنوب السودان‬‎)+211
  • Spain (España)+34
  • Sri Lanka (ශ්‍රී ලංකාව)+94
  • Sudan (‫السودان‬‎)+249
  • Suriname+597
  • Svalbard and Jan Mayen+47
  • Sweden (Sverige)+46
  • Switzerland (Schweiz)+41
  • Syria (‫سوريا‬‎)+963
  • Taiwan (台灣)+886
  • Tajikistan+992
  • Tanzania+255
  • Thailand (ไทย)+66
  • Timor-Leste+670
  • Togo+228
  • Tokelau+690
  • Tonga+676
  • Trinidad and Tobago+1
  • Tunisia (‫تونس‬‎)+216
  • Turkey (Türkiye)+90
  • Turkmenistan+993
  • Turks and Caicos Islands+1
  • Tuvalu+688
  • U.S. Virgin Islands+1
  • Uganda+256
  • Ukraine (Україна)+380
  • United Arab Emirates (‫الإمارات العربية المتحدة‬‎)+971
  • United Kingdom+44
  • United States+1
  • Uruguay+598
  • Uzbekistan (Oʻzbekiston)+998
  • Vanuatu+678
  • Vatican City (Città del Vaticano)+39
  • Venezuela+58
  • Vietnam (Việt Nam)+84
  • Wallis and Futuna (Wallis-et-Futuna)+681
  • Western Sahara (‫الصحراء الغربية‬‎)+212
  • Yemen (‫اليمن‬‎)+967
  • Zambia+260
  • Zimbabwe+263
  • Åland Islands+358
United States

  • US Office

    • we use cookies
    to enhance your experience